Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

An announcement from Wallenstam AB ( ($SE:WALL.B) ) is now available. Wallenstam has launched a revised framework for green financing in ...

Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while ...

Senzime AB ( ($SE:SEZI) ) just unveiled an announcement. Senzime AB has secured a significant order from a leading NHS hospital trust in the UK ...

UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation ...

UPPSALA, SE / ACCESS Newswire / December 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) today announced that one of the leading NHS hospital trusts in the United Kingdom (UK) has ...

We Can, a new comic‑book and animation series, asks bluntly: if we can achieve miracles, why are we still promoting destruction?

The development comes after ReOrbit bagged €45 million in the largest all-equity Series A round in Finland ...

The new treatment stands out because it lowers blood sugar and helps the body burn fat without causing a loss of appetite or ...

Their findings suggest that it may be possible to lower blood sugar and increase fat burning without making people lose their ...